Oppenheimer Holdings Inc Stock News

Barnes Group Inc. (NYSE:B) Stock analysts at Oppenheimer decreased their FY2021 earnings per share (EPS) estimates for shares of Barnes Group in a report released on Wednesday, December 15th. Oppenheimer analyst C. Glynn now anticipates that the industrial products company will post earnings of $1.83 per share for the year, down from their previous [] The post Barnes Group Inc. (NYSE:B) to Post FY2021 Earnings of $1.83 Per Share, Oppenheimer Forecasts appeared first on ETF Daily News .

Medtronic (NYSE:MDT) had its price objective reduced by Oppenheimer from $145.00 to $136.00 in a report published on Friday morning, PriceTargets.com reports. They currently have an outperform rating on the medical technology companys stock. Other equities research analysts have also issued reports about the company. UBS Group lifted their price objective on Medtronic from $145.00 []

Oracle (NYSE:ORCL) has been assigned a $94.00 target price by investment analysts at UBS Group in a research report issued to clients and investors on Friday, Borsen Zeitung reports. UBS Groups price target suggests a potential downside of 2.71% from the companys current price. Other equities analysts have also issued reports about the company. Oppenheimer []

The Goldman Sachs Group began coverage on shares of UnitedHealth Group (NYSE:UNH) in a report released on Tuesday, Analyst Ratings Network reports. The firm issued a buy rating and a $535.00 price target on the healthcare conglomerates stock. A number of other equities research analysts also recently weighed in on the company. Oppenheimer lifted their []

Investment analysts at Oppenheimer began coverage on shares of Eloxx Pharmaceuticals (NASDAQ:ELOX) in a note issued to investors on Thursday, Price Targets.com reports. The brokerage set an outperform rating and a $4.00 price target on the stock. Oppenheimers price target suggests a potential upside of 441.27% from the stocks previous close. ELOX has been the []

OSI Systems, Inc. (NASDAQ:OSIS) shares hit a new 52-week low during trading on Wednesday . The company traded as low as $87.97 and last traded at $93.71, with a volume of 216734 shares trading hands. The stock had previously closed at $92.13. A number of brokerages recently commented on OSIS. Oppenheimer reissued a “buy” rating […]

Was the stock's sharp pullback on Wednesday an overreaction?

Desktop Metal, Inc. (NYSE:DM) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $5.36 and last traded at $5.46, with a volume of 8968 shares. The stock had previously closed at $5.49. Several analysts have recently issued reports on DM shares. Oppenheimer initiated coverage on shares of [] The post Desktop Metal (NYSE:DM) Hits New 52-Week Low at $5.36 appeared first on ETF Daily News .

Investors are always on the lookout for untapped opportunities. Looking at the case for BioCryst Pharmaceuticals (BCRX), Oppenheimers Justin Kim thinks that the bi

Shares of Editas Medicine, Inc. (NASDAQ:EDIT) gapped up before the market opened on Monday . The stock had previously closed at $29.01, but opened at $30.50. Editas Medicine shares last traded at $30.55, with a volume of 12,204 shares trading hands. Several equities analysts recently issued reports on the stock. Oppenheimer raised shares of Editas []

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Oppenheimer issued their FY2021 earnings estimates for shares of Opiant Pharmaceuticals in a research report issued on Wednesday, December 8th. Oppenheimer analyst L. Gershell expects that the technology company will earn $0.26 per share for the year. Oppenheimer has a Outperform rating and a $42.00 price target on the stock. []

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If BNGO stock reaches Oppenheimers price target, investors are looking at a return of more than 300%, plus long-term growth potential. The post This Analysts Saphyr Calculations Suggest Buying Bionano While Its Down appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First